Exosomes derived from hTERT-immortalized cells delay cellular senescence of human fibroblasts.
Exp Gerontol
; 194: 112508, 2024 Sep.
Article
in En
| MEDLINE
| ID: mdl-38986855
ABSTRACT
hTERT gene therapies hold significant promise for treating age-related diseases. However, further research is required to address the challenges of delivery and ethical considerations. We hypothesized that exosomes derived from hTERT-immortalized cells could function similarly to hTERT gene therapies by maintaining telomere length and attenuating cellular senescence biomarkers. In this study, we overexpressed the hTERT gene in Human Foreskin Fibroblast-1 cells (HFF cells) to produce hTERT-immortalized HFF cells (hT-HFF cells). We then used exosomes derived from these hT-HFF cells to treat human fibroblasts, HFF cells. Our results demonstrated that these exosomes effectively attenuated biomarkers of cellular senescence in HFF cells. Furthermore, analysis revealed that hTERT mRNA was indeed packaged into the exosomes from hT-HFF cells. This mRNA was capable of elongating telomeres and delaying cellular senescence in HFF cells. Therefore, exosomes from hT-HFF cells show potential as a treatment for age-related diseases.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cellular Senescence
/
Telomerase
/
Exosomes
/
Fibroblasts
Limits:
Humans
Language:
En
Journal:
Exp Gerontol
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
United kingdom